Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Adverse Drug Events: early-phase trial registry

1 of 7 indexed Adverse Drug Events trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2,497 of 28,707 conditions by registered trial count.

7 US clinical trials · 1 currently recruiting · #2,497 of 28,707 conditions by registered trial count

Adverse Drug Events: 7 US clinical trials tracked, 1 recruiting.

Adverse Drug Events is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is US Department of Veterans Affairs, running 1 of these trials.

Enrollment posture brief

Registry condition adverse-drug-events

OPEN 1 | RECR 14% | LATE 0 | EARLY 1 | RANK #2497 | SPON 1

Nearest open-share peer: Allergic Conjunctivitis (14% recruiting · 21 trials)

ACL Tear71.4%ACL57.1%Acute Myelogenous Leukemia42.9%Acne Scars28.6%Adverse Drug Events (this)14%
Open-enrollment share among volume-matched conditions near Adverse Drug Events

Adverse Drug Events lists 1 open slots (14% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Adverse Drug Events on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Adverse Drug Events is recruiting below its size-band peers.

    1 of 7 indexed trials (14.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Adverse Drug Events trials is spread across many organizations.

    US Department of Veterans Affairs accounts for 1 of 7 trials (14.3%). 7 distinct sponsors appear on at least one study for this condition label.

  3. Typical Adverse Drug Events enrolment sits around 240 participants.

    Median target enrolment is 240 among the 7 trials that report a genuine target (sentinel values excluded). 1 of those (14.3%) plan for fewer than 100 participants.

  4. Adverse Drug Events research is mostly interventional.

    6 interventional and 1 observational studies make up this index (85.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Named interventions

Most-linked intervention names on Adverse Drug Events records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Active medication monitoring Behavioral
1 trials
SMMRT Other
1 trials
Patient risk profiling (potential ADEs) w/provider feedback Behavioral
1 trials
Basic Clinical Decision Support Other
1 trials
Mentored medication reconciliation quality improvement Other
1 trials
Routine Care Other
1 trials
DNA care pathway Other
1 trials

US sites by state

Facility locations filed on Adverse Drug Events trials. A trial with sites in several states counts in each.

Massachusetts 3 trials
California 2 trials
Utah 1 trials
South Dakota 1 trials
Pennsylvania 1 trials
North Carolina 1 trials
Indiana 1 trials
Illinois 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Adverse Drug Events page

7 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Adverse Drug Events condition card totals 7 registered trials; most-linked intervention Active medication monitoring; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.